Sundrug Co.,Ltd. (TYO:9989)
4,623.00
-16.00 (-0.34%)
Sep 10, 2025, 3:30 PM JST
Sundrug Revenue
Sundrug had revenue of 207.70B JPY in the quarter ending June 30, 2025, with 6.75% growth. This brings the company's revenue in the last twelve months to 814.94B, up 6.64% year-over-year. In the fiscal year ending March 31, 2025, Sundrug had annual revenue of 801.81B with 6.66% growth.
Revenue (ttm)
814.94B
Revenue Growth
+6.64%
P/S Ratio
0.67
Revenue / Employee
114.06M
Employees
7,145
Market Cap
542.61B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 801.81B | 50.03B | 6.66% |
Mar 31, 2024 | 751.78B | 61.32B | 8.88% |
Mar 31, 2023 | 690.46B | 41.73B | 6.43% |
Mar 31, 2022 | 648.73B | 14.42B | 2.27% |
Mar 31, 2021 | 634.31B | 16.54B | 2.68% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.21B |
HOYA Corporation | 876.09B |
Takeda Pharmaceutical Company | 4,480.25B |
Daiichi Sankyo Company | 1,924.68B |
Otsuka Holdings | 2,401.70B |
Terumo | 1,037.94B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |